Navigation Links
Red Cross Poll Shows Parents Still Lack H1N1 Information From Schools
Date:8/7/2009

s, feeds and counsels victims of disasters; supplies nearly half of the nation's blood; teaches lifesaving skills; provides international humanitarian aid; and supports military members and their families. The Red Cross is a charitable organization -- not a government agency -- and depends on volunteers and the generosity of the American public to perform its mission. For more information, please visit www.redcross.org or join our blog at www.redcrosschat.org.


'/>"/>
SOURCE American Red Cross
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Blue Cross Blue Shield of Michigan, Michigan Attorney General and Michigan Office of Financial and Insurance Regulation Near Agreement on Rate Increases on Under Age 65 Individual Products
2. Efforts by Blue Cross Blue Shield of Michigan, Physician Practices Help Michigan Become a Leading Adopter of E-prescribing
3. Blue Cross and Blue Shield Association Introduces Interactive Navigation Solution That Helps Individuals and Families Find Healthcare Coverage Options
4. Larry Schreiber Named President of Anthem Blue Cross and Blue Shield in Wisconsin
5. Anthem Blue Cross and Blue Shield in Missouri Harnesses Social Media to Interact with Members
6. Judge Sues Blue Cross for Autism Treatment
7. Blue Cross and Blue Shield of Texas Collaborates With Five Blue Plans to Increase Transparency, Expand Access to Health Care Cost Information
8. WellPoint, BCBSA, Blue Cross Blue Shield of Florida and HCSC Collaborate to Expand Access to Health Care Cost Information
9. Eagles to Host 2nd Annual American Red Cross Training Camp Blood Drive
10. People Across the Country are Making The Switch!
11. Nitrous gases and zinc in the crosshairs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ewswire/-UploadableUSBpedometersmaybenew,butthey,r...vancedaccelerometerfunctionalityandautomateddataup...f-reporteddata.It,snowpossibletoaccuratelygaugeand..., CoreHealthTechnologiesisoneofthefirstwellnesssup...esareeasytoadministerandparticipatein...aninspirat...
(Date:11/27/2009)...tech firm Replikins Ltd. today issued its latest b.... It shows that the lethality of the virus has dr...irus,s current outbreak in the spring of 2009 to r...0.1). The H1N1 infectivity count, however, remains...EB) November 27, 2009 -- Biotech firm Replikins Lt...
(Date:11/27/2009)...ire-USNewswire/--Consideredahighlyriskyandcontrove...splantationisnowalife-savingmainstreamoperationtha...nspearOperaHouseinDallasonNov.11.Leaderscametogeth...thanniversaryofBaylorRegionalTransplantInstitute(B...itedStates. ,, Itwas25yearsagothatBaylorHealthC...
(Date:11/27/2009)...RNewswire-FirstCall/--TheGymboreeCorporation(Nasda...sentattheNASDAQOMX23rdInvestorProgram,whichwillbeh...ecember2,2009,at11:45a.m.GMT. ,, Tolistentoaliv...ertheInternet,pleaselogontowww.gymboree.com,clicko...MediaRelations"andthen"ConferenceCalls&Webcast...
(Date:11/27/2009).../PRNewswire-USNewswire/--Preventingdiseaseisthegoa...newvaccinesarebeingaddedtoassistindiseasepreventio...ime?And,ifnot,whenareadditional,boostershots,neede...ediatrics,theJournaloftheAmericanAcademyofPediatri...alResearchInstitute,basedatRochesterGeneralHospita...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced ...,the first quarter ended July 25, 2008 of its fisc...1, 2008 at 8:00 AM EDT. The company will conduct,a...isten to the conference call live by telephone dia...
...ay lead to tailor-made cells to treat fatal diseas...HealthDay News) -- Scientists have turned skin cel...tor neurons that are genetically identical to the ...better understanding of the disease and, one day, ...
... Connextions, Technologies Help plans at... Orlando, FL (Vocus) July 31, 2008 -- ... Marketing Applications vendor in its "Hype C...manage individual and small group members. , , ,...
...me, Vision Also Announced, ROCHESTER, Mich., July...approved the appointment of Robert,Folberg, M.D., ...ool,Oakland will open with Beaumont Hospitals in 2...hool of Medicine (OUWBSM),-- and that philanthropi...
...N.J., July 31 Kenneth O.,Klepper, president & chi...,(NYSE: MHS ), is scheduled to address the BMO Ca...in New York on Wednesday, Aug. 6, 2008., The pres...resentation may be heard live via a simulcast link...
...cintegrity.org/investigations/pesticides , Center...ASHINGTON, July 31 According to a new,Center for ...Pesticides,( http://www.publicintegrity.org/invest...ides in the United States in 2007,up from just 15 ...
Other Medicine News:Health News:Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 3Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 2Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 3Health News:OU, Beaumont Name Dean of New Medical School 2Health News:OU, Beaumont Name Dean of New Medical School 3Health News:Medco to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference 2Health News:'Safe' Pesticides Now First in Poisonings 2Health News:'Safe' Pesticides Now First in Poisonings 3
(Date:11/25/2009)...stCall/--ERT(Nasdaq: ERES ),announcedtodaythatDr.M...ithSchneck,theCompany,sExecutiveVicePresidentandCF...HealthCareConferenceat1:30PMESTonDecember1,2009inN...ssthepresentationbyvisitingtheCompany,scorporatewe...essedat http://www.corporate-ir.net/ireye/conflobb...
(Date:11/25/2009)...USNewswire/--RemediumTechnologiesInc.,acompanydeve...g,wonfirstprizeand$10,000intheMostPromisingSecurit...anyofficialsannouncetoday. ,, Selectedfrommoret...hedtheirinventionattheGSCSecuritySummitconferenceh...w.remediumtechnologies.com )isdevelopingahigh-pres...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...nt-AGlobalMarketPerspective ,, http://www.re...Global-Market-Perspective.html ,, Risingincide...gnationsisaprincipalfactorinfluencinggrowthinthema...reastcancerhasallowedwomentocomeforwardfortheiryea...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Extending treatment after liver transplant may benefit patients with hepatitis C recurrence 60452 1Extending treatment after liver transplant may benefit patients with hepatitis C recurrence 60452 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 1BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 2BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 4BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 5BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 6BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 7
...tro Assays Show rBChE Suppresses Amyloid Plaque,Fo...ene, Inc., a leading,biodefense company specializi...ical countermeasures against chemical and,biologic...ts,recombinant butyrylcholinesterase (rBChE) resea...ernational Conference on,Alzheimer,s and Parkinson...
...T, N.J., April 04, 2007 /PRNewswire-FirstCall/ -- ...perative Oncology Group,(ECOG) has reported that i...liminary results from a large, randomized clinical...myeloma has found,that the use of a low dose of de...omide suggests survival advantage for,patients whe...
Other Medicine Technology:Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7
... access wire into the renal pelvis through a 21 ga...andril type shaft construction provides rigidity w...) diameter wire guide. The distal portion of the w...tapered mandril which provides tip flexibility. Su...
Two-Part Trocar Needles - Standard
Skinny Needle® (With Chiba Tip) - Standard
Fiberoptic Light Guide with Fixed ACMI™ Light Source End
Medicine Products: